🇪🇺 Codeine Addiction Treatment · Greece

Codeine dependence can develop quietly, often beginning with a legitimate prescription for pain or cough relief. Across Europe, including Greece, misuse of over-the-counter and prescription codeine is a growing concern, with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reporting that opioid-related treatment admissions remain significant in Southern Europe. At European Addiction Centers, we connect you with accredited, private clinics across Greece that specialise in medically supervised detox and evidence-based therapy. Our network ensures you receive comprehensive care tailored to your needs, from initial assessment to aftercare. If you or someone you know is struggling, our team is ready to guide you toward effective, confidential support. For more on our approach, visit our dedicated page on Codeine Addiction Treatment.

Codeine is classified as a controlled substance under Greek law (Law 3459/2006), and its non-prescription sale is prohibited. Despite this, the EMCDDA’s 2023 report notes that opioid use, including pharmaceutical opioids like codeine, accounts for approximately 15% of all drug-related treatment entries in Greece. In major urban centres like Athens and Thessaloniki, the availability of codeine through illegal online pharmacies and diverted prescriptions remains a challenge. The Greek National Public Health Organisation (EODY) has identified a rise in opioid-related emergency visits, particularly among individuals aged 25–44. Cultural stigma around addiction, especially in family-oriented communities, often delays treatment-seeking behaviour. However, Greece’s public health system offers some state-funded detox programmes, though waiting lists can be long. For those seeking faster, private care, our partner clinics provide immediate access. To learn more about available facilities, explore our directory of rehab centres in Greece.

Codeine addiction often presents with both physical and psychological symptoms. Physically, individuals may experience constipation, drowsiness, pinpoint pupils, and respiratory depression at higher doses. Psychologically, dependence manifests as cravings, anxiety, irritability, and an inability to stop using despite negative consequences. Tolerance builds quickly, meaning more codeine is needed to achieve the same effect, which can escalate to the use of stronger opioids. Co-occurring mental health conditions—such as depression, post-traumatic stress disorder, or chronic pain syndromes—are common and require integrated dual diagnosis treatment. The impact on family and work is profound: relationship breakdowns, financial strain, and reduced occupational performance are frequent. Recognising these signs early is crucial for effective intervention and a stable recovery.

Greece offers a range of private treatment settings for codeine dependence, all accessible through EAC’s network of accredited partner clinics. Options include residential (inpatient) programmes, which provide 24/7 medical supervision and structured therapy in a safe environment, typically lasting 28 to 90 days. Day programmes and intensive outpatient services allow clients to live at home while attending daily therapy sessions. Medically assisted detox (MAT) using buprenorphine or naltrexone is available to manage withdrawal symptoms safely. Evidence-based therapies such as Cognitive Behavioural Therapy (CBT), Dialectical Behaviour Therapy (DBT), and 12-step facilitation are standard, along with trauma-informed approaches like EMDR where needed. All partner clinics operate with multilingual staff, adhere to strict GDPR confidentiality, and offer culturally sensitive care. Whether you need treatment in Athens, Crete, or a quieter coastal setting, EAC connects you with the right clinic.

Greece offers a range of private treatment settings for codeine dependence, all accessible through EAC’s network of accredited partner clinics. Options include residential (inpatient) programmes, which provide 24/7 medical supervision and structured therapy in a safe environment, typically lasting 28 to 90 days. Day programmes and intensive outpatient services allow clients to live at home while attending daily therapy sessions. Medically assisted detox (MAT) using buprenorphine or naltrexone is available to manage withdrawal symptoms safely. Evidence-based therapies such as Cognitive Behavioural Therapy (CBT), Dialectical Behaviour Therapy (DBT), and 12-step facilitation are standard, along with trauma-informed approaches like EMDR where needed. All partner clinics operate with multilingual staff, adhere to strict GDPR confidentiality, and offer culturally sensitive care. Whether you need treatment in Athens, Crete, or a quieter coastal setting, EAC connects you with the right clinic.

1. 1. Free Confidential Assessment: You contact us via phone or our online form. A trained advisor will discuss your situation, answer questions, and schedule a same-day clinical assessment.
2. 2. Personalised Treatment Plan: A specialist reviews your medical history, level of dependence, and any co-occurring conditions to create a tailored plan.
3. 3. Placement and Admission: We match you with an accredited partner clinic in Greece that fits your needs and preferences. Admission is arranged within 24–48 hours.
4. 4. Treatment Programme: Depending on severity, a typical codeine programme lasts 4–12 weeks and includes detox, individual and group therapy, and holistic support.
5. 5. Aftercare and Relapse Prevention: Before discharge, a comprehensive aftercare plan is developed, including ongoing therapy, peer support groups, and relapse prevention strategies.